Neuralink has made strides in restoring communication for individuals with severe speech impairments.
Recently, the US Food and Drug Administration (FDA) has granted the company a Device Designation for its innovative brain-chip technology.
This designation is awarded to the medical devices that promise more effective treatment for life-threatening conditions.
The device would help those affected by amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, cerebral palsy, multiple sclerosis, and some other neurological conditions.
Neuralink was a neurotechnology company founded by Elon Musk.